BIO-RAD LABS INC.DL-,0001BIO-RAD LABS INC.DL-,0001BIO-RAD LABS INC.DL-,0001

BIO-RAD LABS INC.DL-,0001

No trades
See on Supercharts
Next report date
Report period
Q1 2024
EPS estimate
1.99EUR
Revenue estimate
‪573.76 M‬EUR
Market capitalization
‪7.37 B‬EUR
−19.4EUR
‪−577.42 M‬EUR
‪2.42 B‬EUR
‪19.68 M‬
Beta (1Y)
1.74

About Bio-Rad Laboratories, Inc.

CEO
Norman D. Schwartz
Headquarters
Hercules
Employees (FY)
‪8.03 K‬
Founded
1952
FIGI
BBG000C08SN0
Bio-Rad Laboratories, Inc. engages in the development and production of specialty chemicals used in biochemical, pharmaceutical, and other life science research applications. It operates through the Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets reagents, apparatus, and laboratory instruments. The Clinical Diagnostics segment designs, manufactures, sells, and supports test systems, informatics systems, and test kits. The company was founded by David S. Schwartz and Alice N. Schwartz in 1952 and is headquartered in Hercules, CA.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬

See all ideas 

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

Depending on the exchange, the stock ticker may vary. For instance, on FWB exchange BIO-RAD LABS INC.DL-,0001 stocks are traded under the ticker BUWA.
BIO-RAD LABS INC.DL-,0001 is going to release the next earnings report on May 7, 2024. Keep track of upcoming events with our Earnings Calendar.
BUWA earnings for the last quarter are 2.20 EUR per share, whereas the estimation was 2.63 EUR resulting in a −16.25% surprise. The estimated earnings for the next quarter are 2.55 EUR per share. See more details about BIO-RAD LABS INC.DL-,0001 earnings.
BIO-RAD LABS INC.DL-,0001 revenue for the last quarter amounts to ‪597.99 M‬ EUR despite the estimated figure of ‪652.27 M‬ EUR. In the next quarter revenue is expected to reach ‪620.61 M‬ EUR.
Yes, you can track BIO-RAD LABS INC.DL-,0001 financials in yearly and quarterly reports right on TradingView.
BUWA net income for the last quarter is ‪316.84 M‬ EUR, while the quarter before that showed ‪100.52 M‬ EUR of net income which accounts for 215.21% change. Track more BIO-RAD LABS INC.DL-,0001 financial stats to get the full picture.
No, BUWA doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, BUWA shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade BIO-RAD LABS INC.DL-,0001 stock right from TradingView charts — choose your broker and connect to your account.
BUWA reached its all-time high on Sep 13, 2021 with the price of 700.0 EUR, and its all-time low was 18.2 EUR and was reached on Mar 26, 2001.
See other stocks reaching their highest and lowest prices.
As of Apr 30, 2024, the company has ‪8.03 K‬ employees. See our rating of the largest employees — is BIO-RAD LABS INC.DL-,0001 on this list?
We've gathered analysts' opinions on BIO-RAD LABS INC.DL-,0001 future price: according to them, BUWA price has a max estimate of 411.51 EUR and a min estimate of 327.34 EUR. Read a more detailed BIO-RAD LABS INC.DL-,0001 forecast: see what analysts think of BIO-RAD LABS INC.DL-,0001 and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. BIO-RAD LABS INC.DL-,0001 EBITDA is ‪533.88 M‬ EUR, and current EBITDA margin is 21.57%. See more stats in BIO-RAD LABS INC.DL-,0001 financial statements.